HALOZYME THERAPEUTICS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- HALOZYME THERAPEUTICS, INC. treasury stock, shares, acquired for the quarter ending 2022-03-31 was 4.60M shares, a 29.23% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. treasury stock, shares, acquired for the quarter ending 2021-03-31 was 6.50M shares.
- HALOZYME THERAPEUTICS, INC. treasury stock, shares, acquired for fiscal 2020 was 6.50M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2022-12-31 | 4.50M shares 10-Q · filed 2024-05-07 | |
| 2022-03-31 | 4.60M shares 10-Q · filed 2022-08-09 | |
| 2021-12-31 | 3.90M shares 10-Q · filed 2024-05-07 | |
| 2021-03-31 | 6.50M shares 10-Q · filed 2022-08-09 | |
| 2020-12-31 | 6.50M shares 10-K · filed 2023-02-21 | |
| 2019-12-31 | 11.10M shares 10-Q · filed 2021-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |